See all news

Local start-up getting attention for developing cancer treatments

David T. Curiel, MD, PhD

St. Louis start-up company Unleash Immuno Oncolytics is developing viruses that are specific for fighting cancer. Read full article at KMOV.com »

Categories: Cancer Biology Division, Department News, Grants & Awards, Research